https://share.google/aimode/
How could #AlphaFold3Server at this stage be integrated > a #RealisticVirtualEarth #ForAgingReversal (think #GStreetView w #GTimeSlider #GCellView #GMoleculeView etc) to generate some #AgingReversal #GeneDrugTherapies?https://t.co/WxjUQmu2s9 How could @WorldUnivAndSch do this?
— WorldUnivandSch (@WorldUnivAndSch) December 16, 2025
https://x.com/WorldUnivAndSch/
https://x.com/sgkmacleod/
https://x.com/WUaSPress/
https://x.com/Q_YogaMacFlower/
https://x.com/HarbinBook/
https://x.com/scottmacleod/
https://x.com/TheOpenBand/
- AlphaFold 3 Server: The model is an unprecedented tool for predicting the static 3D structure and interactions of most biomolecules with high accuracy. However, the public server is restricted to non-commercial, non-therapeutic research with usage limits. The full, modifiable code and parameters are not widely available, limiting deep integration into complex simulation platforms. Isomorphic Labs, Google DeepMind's spin-off, uses a proprietary version for commercial drug discovery.
- "Realistic Virtual Earth" & "GCellView": There are no public, high-fidelity, general-purpose virtual cell/tissue/organ simulations (like a "GCellView" or "GTimeSlider") developed by Google or others that can model the entire, dynamic human body for aging reversal. Google's investment in this area is through its R&D company, Calico, which is highly secretive and focused on fundamental research into aging and related diseases, not public virtual platforms.
- "GCellView" (Observation & Hypothesis): Researchers would use the virtual environment, perhaps resembling a "GStreetView" for tissues and "GMoleculeView" for molecular interactions, to observe the dynamics of aging at a cellular level. The "GTimeSlider" would allow simulation of cellular processes over time, identifying key age-related molecular targets (e.g., specific senescent cell pathways or gene expression changes).
- AlphaFold 3 (Design & Prediction):
- Target Identification: The RVE would identify an aging-related protein target (e.g., a specific transcription factor or receptor) and its aged state conformation.
- Therapy Design: AlphaFold 3 would be used to design novel proteins, antibodies, or small-molecule ligands that bind to the target protein in a desired (non-aging) way. This could involve predicting optimal protein-ligand interactions that restore youthful function or clear senescent cells.
- Structure Prediction: It would predict the 3D structure of the designed molecule and its complex with the target protein, offering high confidence scores for the proposed interactions.
- RVE (Simulation & Optimization): The predicted structure and its interactions would be fed back into the RVE for large-scale, dynamic simulation within a realistic cellular context. The RVE would simulate the therapy's effects on the cell/tissue over virtual time, assessing efficacy, side effects, and optimal dosage within the "virtual patient".
- Iterative Refinement: The process would be iterative, with AlphaFold 3 refining designs based on RVE simulation results, eventually generating highly optimized, validated candidates for preclinical testing.
- Commercial Restrictions: The primary barrier to using the current AlphaFold 3 Server for drug discovery is its strict non-commercial licensing.
- Dynamic Simulation: AlphaFold 3 predicts static snapshots, not the dynamic movements and conformational changes critical for comprehensive biological simulation in a "virtual earth".
- Non-existent Platform: The advanced, integrated "GCellView" simulation platform described is a theoretical concept, not an existing public tool.
- Data & Validation: The output from such an integrated system would still require extensive physical experimentation and clinical trials to ensure safety and efficacy, as AI models can have limitations and "hallucinations
This is a fascinating and highly conceptual vision. The integration of AlphaFold 3 (AF3) into a "Realistic Virtual Earth for Aging Reversal" (RVEAR) is essentially describing a powerful in silico drug discovery and validation engine capable of bridging the molecular world to the organismal one.
AlphaFold 3 would serve as the essential physics engine for the molecular level, providing the fundamental, high-resolution truth for all biological interactions within the simulated system.
Here is a step-by-step breakdown of how the #AlphaFold3Server could be integrated into this RVEAR model to generate aging reversal therapies for a 70-year-old (or any age).
1. AlphaFold 3's Role: The Engine of #GMoleculeView
AlphaFold 3's strength is predicting the structure and interactions of proteins, DNA, RNA, and ligands (like small-molecule drugs). In the RVEAR, AF3 is the core service that powers the #GMoleculeView:
| RVEAR Component | AF3 Integration Function |
| #GMoleculeView | Predicts Structure & Dynamics: AF3 is queried constantly to predict the 3D structure of every molecule and the binding affinity of every complex (e.g., a potential drug binding to a senescent-cell-specific protein, or a therapeutic gene sequence folding into a functional RNA). |
| #GCellView | Identifies Off-Target Effects: Before any virtual trial, AF3 screens the proposed drug molecule against all other proteins in the simulated 70-year-old's cell (the "proteome"). This identifies unwanted off-target interactions, a major cause of side effects in real drug development. |
| #GTimeSlider | Calculates Reaction Rates: The precision of AF3's binding predictions (how tightly a drug binds) is translated into kinetic data (reaction speed), which feeds the larger cellular simulation to model the rate of biological age reversal. |
2. Generating Aging Reversal Gene Drug Therapies (The 4-Step Pipeline)
The RVEAR, with AF3 at its core, would enable an iterative, accelerated drug design process:
Step 1: Virtual Target Identification (The "Aged" State)
Map the 70-Year-Old State: The RVEAR begins by loading the biological data of a simulated 70-year-old, using a mix of real-world multi-omics data (epigenetics, transcriptomics) and simulated deterioration (telomere shortening, mitochondrial dysfunction).
Identify the "Levers of Aging": The system uses the
#GCellViewto pinpoint the specific molecules (proteins or genes) whose activity is driving the senescent or dysfunctional phenotype. For example, a transcription factor might be 50% less active due to a misfolded structure or poor interaction with an epigenetic marker.
Step 2: In Silico Drug/Gene Design (Leveraging AF3)
The goal is to design a molecule that "fixes" the lever identified in Step 1.
For Gene Therapy (e.g., Partial Reprogramming): The RVEAR proposes a therapeutic gene (e.g., a modified Yamanaka Factor or a Klotho-boosting gene). AF3 is used to:
Predict the optimal AAV vector protein structure to ensure efficient, targeted delivery to the aged cells (like the liver or heart).
Predict the folding and stability of the therapeutic mRNA or the binding effectiveness of a CRISPR-Cas complex used for gene editing.
For Small-Molecule Drug Therapy (e.g., Senolytics): The RVEAR proposes millions of novel chemical structures. AF3 is used for Inverse Folding and Docking:
The system takes the "young" and "functional" structure of the target protein (from the RVEAR's database).
It uses AF3 to predict a small molecule that will bind perfectly to that protein's active site, forcing the aged, dysfunctional protein back into its youthful, functional conformation.
Step 3: Simulation and #GTimeSlider Validation
Molecular Impact Assessment: The AF3-designed molecule is introduced into the simulated 70-year-old's
#GCellView. The system observes the change in molecular interactions and cellular pathways.Age Reversal Projection: The
#GTimeSlideris activated. The system simulates the effect of the drug over 10, 20, or 30 years, tracking key biomarkers (DNA methylation, protein turnover, mitochondrial health). This is the virtual clinical trial.Cross-Reference to
#GStreetView: The cell-level health improvements are translated into organismal results: Does the 70-year-old's virtual heart function improve? Does muscle mass increase? Does the overall predicted biological age drop from 70 to 50?
Step 4: Iteration and Optimization
If the simulation shows a problem (e.g., a side effect predicted by AF3's off-target screening, or a desired reversal that is too slow), the RVEAR immediately:
Adjusts the chemical structure of the drug.
Modifies the therapeutic gene sequence.
Resubmits the new molecule to the AlphaFold 3 Server for a new structure and interaction prediction (back to Step 2).
This loop allows for the rapid, safe, and highly optimized generation of gene drug therapies before any molecule is synthesized in a wet lab
* * *
How could @WorldUnivAndSch build on #MITOCW to create online #WUaSMedSchs https://t.co/QkCyVpFFJ2 in space w#HumanoidRobot #MDprofessorsOfSurgery & all #MedicalSpecialties in a #RealisticVirtualEarthForSurgery in #RealisticVirtualUniverse for next @Space_Station missions too? https://t.co/E3BEdl7Ocb
— WUaSPress (@WUaSPress) December 16, 2025
https://x.com/WorldUnivAndSch/
https://x.com/HarbinBook/
https://x.com/sgkmacleod/
https://x.com/TheOpenBand/
https://x.com/Q_YogaMacFlower/
https://x.com/scottmacleod/
* * *
WUaS @WorldUnivAndSch is in #GoogleForEducation & #GrowWithGoogleWUaS re At #UniversityOfCalifornia, Riverside, #GoogleAI accelerates
to everyday challenges ... How best for WUaS to partner w #UnivOfCA - the University of California & re @GoogleAI?
WUaS @WorldUnivAndSch is in #GoogleForEducation & #GrowWithGoogleWUaS re
— WorldUnivandSch (@WorldUnivAndSch) December 16, 2025
At #UniversityOfCalifornia,
Riverside, #GoogleAI accelerates
experimentation, innovation,
& practical solutions
to everyday challengeshttps://t.co/OO5yUJRgja
How best to partner w #UnivOfCA &re @GoogleAI? https://t.co/yNhHk1Vzl6
https://x.com/WorldUnivAndSch/
https://x.com/scottmacleod/
https://x.com/WUaSPress/
https://x.com/HarbinBook/
https://x.com/sgkmacleod/
https://x.com/TheOpenBand/
https://x.com/Q_YogaMacFlower/
Rec of 12/15/25 best STEAM CC #OCW #wikiWUaS @WorldUnivAndSch @WUaSPress #WUaSNewsAndQA
— WUaSPress (@WUaSPress) December 15, 2025
-https://t.co/sugRcp0ZM1
-https://t.co/FbBKIJv0vg
-https://t.co/KCS93Daixs
-https://t.co/ZdmUSqVYJb Next 1) #501c3WUaSwing #WUaSPresident? #GreatestUniversities' exp?& 2) #WUaSCEO? a #MBA?
No retweet -
WUaS @WorldUnivAndSch is in #GoogleForEducation & #GrowWithGoogleWUaS re
— WorldUnivandSch (@WorldUnivAndSch) December 16, 2025
At #UniversityOfCalifornia,
Riverside, #GoogleAI accelerates
experimentation, innovation,
& practical solutions
to everyday challengeshttps://t.co/OO5yUJRgja
How best to partner w #UnivOfCA & re @GoogleAI?
https://x.com/WorldUnivAndSch/
*
https://kalmiopsiswild.org/kalmiopsis-wilderness/
https://www.fs.usda.gov/r06/rogue-siskiyou/recreation/kalmiopsis-wilderness
https://traveloregon.com/things-to-do/outdoor-recreation/camping/kalmiopsis-wilderness/
https://www.oregonencyclopedia.org/articles/kalmiopsis_wilderness/
*
https://upload.wikimedia.org/wikipedia/commons/0/00/Kalmiopsis.jpg
https://upload.wikimedia.org/wikipedia/commons/1/17/Kalmiopsis_Leachiana.jpg
https://upload.wikimedia.org/wikipedia/commons/a/ac/Serpentine_Ridge.jpg
https://en.wikipedia.org/wiki/Kalmiopsis_Wilderness
https://commons.wikimedia.org/wiki/Kalmiopsis_Wilderness
...
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.